Holen Sie sich die Stockscreener-App
33.02
3.32%
1.06
Handel nachbörslich:
33.10
0.08
+0.24%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$31.96
Offen:
$31.77
24-Stunden-Volumen:
6.93M
Relative Volume:
2.00
Marktkapitalisierung:
$16.86B
Einnahmen:
$15.00B
Nettoeinkommen (Verlust:
$2.48B
KGV:
6.4745
EPS:
5.1
Netto-Cashflow:
$514.00M
1W Leistung:
-3.51%
1M Leistung:
-10.42%
6M Leistung:
-6.33%
1J Leistung:
-6.88%
1-Tages-Spanne:
$31.75
$33.22
1-Wochen-Bereich:
$31.60
$34.22
52-Wochen-Spanne:
$31.60
$44.01
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(847) 948-2000
Adresse
ONE BAXTER PKWY, DEERFIELD, IL
Vergleichen Sie BAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| BAX | 33.02 | 16.86B | 15.00B | 2.48B | 514.00M | 5.10 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Baxter International providing updates on recovery efforts after Helene - WCNC.com
Baxter International Inc. (NYSE:BAX) Shares Sold by Cincinnati Financial Corp - MarketBeat
Baxter: Deleveraging At A Very Steep Price - Seeking Alpha
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL
Baxter International Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Baxter International on track for end-of-year recovery goal after Helene - WCNC.com
Baxter put volume heavy and directionally bearish - TipRanks
Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Baxter International (NYSE:BAX) Sets New 52-Week LowHere's Why - MarketBeat
Sivik Global Healthcare LLC Has $5.70 Million Stock Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter stock touches 52-week low at $32.4 amid market shifts - Investing.com Canada
Baxter International Inc. (NYSE:BAX) Shares Purchased by Entropy Technologies LP - MarketBeat
Entropy Technologies LP Purchases 15,794 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Baxter to Present at Jefferies London Healthcare Conference - Marketscreener.com
Baxter to split into two companies - Covington News
Baxter International To Present At UBS Global Healthcare Conference; Webcast At 4:15 PM ET - Nasdaq
Decoding Baxter International Inc (BAX): A Strategic SWOT Insight - Yahoo Finance
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter to Present at Stifel 2024 Healthcare Conference - Marketscreener.com
Baxter Cuts Dividend by 41% Ahead of Kidney-Care Unit Sale - MarketWatch
Baxter International Inc. Declares Quarterly Dividend, Payable on January 2, 2025 - Marketscreener.com
Baxter Sets $0.17 Dividend Ahead of Kidney Care Sale to Carlyle; 93-Year Payout Streak Continues | CG Stock News - StockTitan
Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR – S&S Insider - GlobeNewswire Inc.
Stifel Nicolaus Lowers Baxter International (NYSE:BAX) Price Target to $38.00 - MarketBeat
Baxter International Becomes Oversold - Nasdaq
Company news: Gaganjot Gill of Baxter International recognized by MACNY - syracuse.com
Baxter Declares Quarterly Dividend - Baxter
Plasma Expander Market Is Booming Worldwide 2024-2031 | Baxter - openPR
Earnings call: Baxter International sees steady growth and recovery post-Hurricane - Investing.com India
Baxter International (NYSE:BAX) Issues Quarterly Earnings Results - MarketBeat
Baxter International Inc. (NYSE:BAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Baxter International Inc (BAX) Q3 2024 Earnings Call Highlights: - GuruFocus.com
Baxter International Inc (BAX) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance
Baxter warns hurricane disruptions at IV facility may hit financials in 2025 - MSN
Baxter International Reports Resilient Q3 2024 Performance - TipRanks
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter shares fall as Q4 guidance disappoints - Investing.com
Chicago hospitals feel relief as Baxter responds to IV fluid shortage - AOL
Baxter cuts guidance on hurricane-related plant shutdown - Crain's Chicago Business
Baxter International (NYSE:BAX) Issues Q4 2024 Earnings Guidance - MarketBeat
Baxter International (NYSE:BAX) Releases FY 2024 Earnings Guidance - MarketBeat
Earnings Summary: Baxter International reports higher sales for Q3 2024 - AlphaStreet
Baxter Expects Hurricane Helene Aftermath To Impact Near-Term Financial Outlook - Benzinga
Baxter (BAX) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Baxter International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Baxter International (NYSE:BAX) Updates Q4 Earnings Guidance - MarketBeat
Baxter International (BAX) Beats Q3 Earnings Estimates - Yahoo Finance
Baxter cuts outlook to reflect hurricane impact - MSN
Baxter International Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024 - Marketscreener.com
Baxter stock slips on cut to outlook (BAX:NYSE) - Seeking Alpha
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.78%
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):